H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy
ACS Nano · 17.02.2026 · 20 (6) · 4953-4969
DOI: 10.1021/acsnano.5c18008 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.02.2026. Verfasst von Jinzhe Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Re…. Hauptthemen laut MEDLINE: Ferroptosis, Immunotherapy, Bismuth, Hydrogen Sulfide. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, BAGUI Scholar Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Scho…
- Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, University Engineerin…
ORCID-Profile: Jinzhe Liang, Shulin Zhao
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- BAGUI Scholar Program
Zitieren
APA
Liang, J., Luo, X., Shi, Y. Q., Yang, L. M., Li, C., Huang, L., Ma, Y., Huang, Y., & Zhao, S. (2026). H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy. ACS Nano, 20(6), 4953-4969. https://doi.org/10.1021/acsnano.5c18008
Vancouver
Liang J, Luo X, Shi YQ, Yang LM, Li C, Huang L, et al. H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy. ACS Nano. 2026;20(6):4953-4969. doi:10.1021/acsnano.5c18008
BibTeX
@article{Liang2026,
author = {Liang, Jinzhe and Luo, Xianliu and Shi, Ya-Qian and Yang, Liang-Mei and Li, Caiying and Huang, Lixian and Ma, Yuzhen and Huang, Yong and Zhao, Shulin},
title = {H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {6},
pages = {4953--4969},
doi = {10.1021/acsnano.5c18008}
}
EUVIMED